Search
Displaying 241–250 of 779 for “retinitis clinical trial”
-
RD Fund Invests in Beacon Therapeutics to Advance XLRP Gene Therapy
Research NewsThe venture philanthropy arm of the Foundation partnered with other investors to support the development of a gene therapy trial for X-linked retinitis pigmentosa (XLRP).
-
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
#GivingTuesdayNow Featured Researcher Dr. Shannon Boye
Research NewsA Lifelong Science Nerd is Winning the Fight Against Blindness
-
Foundation Investing in Drug to Slow Many Forms of RP
Research NewsThe Foundation Fighting Blindness Clinical Research Institute (FFB-CRI) has announced an investment of up to $7.5 million to advance the potential therapy into and through a Phase II clinical trial.
-
A Steady Hand in Saving Vision
Research NewsSubretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
ARVO 2016: What Does It Take to Develop a Stem-Cell Therapy for the Retina?
Research NewsThere are innumerable considerations for researchers developing therapies.
-
Low-Hanging Fruit: Repurposing Drugs to Treat Retinal Diseases
Research NewsBecause repurposing relies on prior research and clinical data, it reduces the cost and time needed to establish a new therapeutic application for the drug.
-
Curing Blindness, Part 1: Corey’s Story
Beacon StoriesHow gene therapy restored some of a boy’s sight.
-
José-Alain Sahel Awarded 2026 ARVO Proctor Medal for Groundbreaking Research Achievements
Research NewsDr. Sahel’s research has led to several emerging retinal disease therapies that have moved into clinical trials.
-
Foundation News
The free, online event at 7 p.m. ET on March 13, 2025, will feature presentations from Christine Kay, MD, Vitreoretinal Associates in Gainesville, Florida, and Thomas Mendel, MD, PhD, Ohio State University Wexner Medical Center.
